These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 36916547
21. Application of R2* and Apparent Diffusion Coefficient in Estimating Tumor Grade and T Category of Bladder Cancer. Wang Y, Shen Y, Hu X, Li Z, Feng C, Hu D, Kamel IR. AJR Am J Roentgenol; 2020 Feb; 214(2):383-389. PubMed ID: 31670586 [Abstract] [Full Text] [Related]
24. A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2 Tumors With Stalk. Cai L, Yu R, Liu P, Zhuang J, Li K, Wu Q, Sun X, Liu Y, Zhou M, Cao Q, Li P, Yang X, Lu Q. J Magn Reson Imaging; 2024 Apr; 59(4):1179-1190. PubMed ID: 37602726 [Abstract] [Full Text] [Related]
25. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade. Kim KW, Kuzmiak CM, Kim YJ, Seo JY, Jung HK, Lee MS. Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079 [Abstract] [Full Text] [Related]
26. Combined T2-weighted and diffusion-weighted MRI for diagnosis of urinary bladder invasion in patients with prostate carcinoma. Ren J, Huan Y, Li F, Wang H, Ge Y, Chang Y, Yin H, Sun L. J Magn Reson Imaging; 2009 Aug; 30(2):351-6. PubMed ID: 19591203 [Abstract] [Full Text] [Related]
27. Accuracy and Challenges in the Vesical Imaging-Reporting and Data System for Staging Bladder Cancer. Meng X, Hu H, Wang Y, Feng C, Hu D, Liu Z, Kamel IR, Li Z. J Magn Reson Imaging; 2022 Aug; 56(2):391-398. PubMed ID: 35049074 [Abstract] [Full Text] [Related]
32. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Lista F, Andrés G, Cáceres F, Ramón de Fata F, Rodríguez-Barbero JM, Angulo JC. Actas Urol Esp; 2013 Aug; 37(7):419-24. PubMed ID: 23773823 [Abstract] [Full Text] [Related]
33. Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy? Al Johi RS, Seifeldein GS, Moeen AM, Aboulhagag NA, Moussa EM, Hameed DA, Imam HM. Cent European J Urol; 2018 Aug; 71(1):31-37. PubMed ID: 29732204 [Abstract] [Full Text] [Related]
34. The Value of Multi-directional High b-Value DWI in the Assessment of Muscular Invasion in Bladder Urothelial Carcinoma: In Comparison with VI-RADS. Zhang X, Yun Y, Wang S, Wang M, Zhang S, Yang D, Chen X, Xu C. Acad Radiol; 2024 Oct 09. PubMed ID: 39389814 [Abstract] [Full Text] [Related]
35. Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer. Ahmed SA, Taher MGA, Ali WA, Ebrahem MAES. Abdom Radiol (NY); 2021 Jun 09; 46(6):2712-2721. PubMed ID: 33547919 [Abstract] [Full Text] [Related]
37. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Ohgiya Y, Suyama J, Sai S, Kawahara M, Takeyama N, Ohike N, Sasamori H, Munechika J, Saiki M, Onoda Y, Hirose M, Gokan T. Magn Reson Med Sci; 2014 Jun 09; 13(3):175-81. PubMed ID: 24990469 [Abstract] [Full Text] [Related]
40. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Kobayashi S, Koga F, Yoshida S, Masuda H, Ishii C, Tanaka H, Komai Y, Yokoyama M, Saito K, Fujii Y, Kawakami S, Kihara K. Eur Radiol; 2011 Oct 09; 21(10):2178-86. PubMed ID: 21688007 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]